Cargando…

Neurological Manifestations in COVID-19 in Three Waves of the Pandemic: An Inpatient Study from India

BACKGROUND: Though severe acute respiratory syndrome coronavirus 2 (SARS CoV 2) virus primarily affects respiratory system, neurological involvement is well known. AIMS: To describe the neurological manifestations of coronavirus disease 2019 (COVID-19) during three waves of the pandemic. METHODOLOGY...

Descripción completa

Detalles Bibliográficos
Autores principales: Kulkarni, Rahul, Gupta, Dulari, Pujari, Shripad, Deshpande, Vishal, Naphade, Pravin, Deshpande, Rushikesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996479/
https://www.ncbi.nlm.nih.gov/pubmed/36911448
http://dx.doi.org/10.4103/aian.aian_204_22
_version_ 1784903051966939136
author Kulkarni, Rahul
Gupta, Dulari
Pujari, Shripad
Deshpande, Vishal
Naphade, Pravin
Deshpande, Rushikesh
author_facet Kulkarni, Rahul
Gupta, Dulari
Pujari, Shripad
Deshpande, Vishal
Naphade, Pravin
Deshpande, Rushikesh
author_sort Kulkarni, Rahul
collection PubMed
description BACKGROUND: Though severe acute respiratory syndrome coronavirus 2 (SARS CoV 2) virus primarily affects respiratory system, neurological involvement is well known. AIMS: To describe the neurological manifestations of coronavirus disease 2019 (COVID-19) during three waves of the pandemic. METHODOLOGY: This was an ambispective observational single-centre study to describe the neurological manifestations of COVID-19 infection among inpatients from a tertiary care referral centre in Western India from March 2020 to January 2022. RESULTS: Out of 14,822 patients admitted with COVID-19, 307 (2.07%) had neurological manifestations. Neurological manifestations were seen in 1.87% in first wave (onset to 10 Feb 21); 2.37% in second wave (Feb 11, 2021 to Dec 31, 2021) and 6.26% in third wave (Jan 1, 2022 to Jan 31, 2022). The most common neurological manifestations were encephalopathy (34.5%), ischemic stroke (32.1%), and acute symptomatic seizures (8.8%). Encephalopathy (p = 0.028) was more common in first wave while seizures were more common in third wave (p = 0.001). In patients with encephalopathy, hypoxia (p = 0.0001), shock (p = 0.001), renal involvement (p = 0.002), and sepsis (p = 0.033) were associated with higher mortality; while those with no systemic involvement had better survival (p = 0.0001). Among patients with ischemic stroke, 32.1% did not have any traditional vascular risk factors. These patients were 9 years younger and required 6 days less hospitalization than patients of stroke with vascular risk factors. CONCLUSION: SARS-CoV-2 produces many central and peripheral nervous system manifestations. Encephalopathy was more common in first wave while acute symptomatic seizures were more common in third wave. Encephalopathy was most common neurological manifestation with progressively higher mortality with increased number of systemic comorbidities. Ischemic stroke was seen in patients who had vascular risk factors as well as in patients without them.
format Online
Article
Text
id pubmed-9996479
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-99964792023-03-10 Neurological Manifestations in COVID-19 in Three Waves of the Pandemic: An Inpatient Study from India Kulkarni, Rahul Gupta, Dulari Pujari, Shripad Deshpande, Vishal Naphade, Pravin Deshpande, Rushikesh Ann Indian Acad Neurol Original Article BACKGROUND: Though severe acute respiratory syndrome coronavirus 2 (SARS CoV 2) virus primarily affects respiratory system, neurological involvement is well known. AIMS: To describe the neurological manifestations of coronavirus disease 2019 (COVID-19) during three waves of the pandemic. METHODOLOGY: This was an ambispective observational single-centre study to describe the neurological manifestations of COVID-19 infection among inpatients from a tertiary care referral centre in Western India from March 2020 to January 2022. RESULTS: Out of 14,822 patients admitted with COVID-19, 307 (2.07%) had neurological manifestations. Neurological manifestations were seen in 1.87% in first wave (onset to 10 Feb 21); 2.37% in second wave (Feb 11, 2021 to Dec 31, 2021) and 6.26% in third wave (Jan 1, 2022 to Jan 31, 2022). The most common neurological manifestations were encephalopathy (34.5%), ischemic stroke (32.1%), and acute symptomatic seizures (8.8%). Encephalopathy (p = 0.028) was more common in first wave while seizures were more common in third wave (p = 0.001). In patients with encephalopathy, hypoxia (p = 0.0001), shock (p = 0.001), renal involvement (p = 0.002), and sepsis (p = 0.033) were associated with higher mortality; while those with no systemic involvement had better survival (p = 0.0001). Among patients with ischemic stroke, 32.1% did not have any traditional vascular risk factors. These patients were 9 years younger and required 6 days less hospitalization than patients of stroke with vascular risk factors. CONCLUSION: SARS-CoV-2 produces many central and peripheral nervous system manifestations. Encephalopathy was more common in first wave while acute symptomatic seizures were more common in third wave. Encephalopathy was most common neurological manifestation with progressively higher mortality with increased number of systemic comorbidities. Ischemic stroke was seen in patients who had vascular risk factors as well as in patients without them. Wolters Kluwer - Medknow 2022 2022-05-03 /pmc/articles/PMC9996479/ /pubmed/36911448 http://dx.doi.org/10.4103/aian.aian_204_22 Text en Copyright: © 2022 Annals of Indian Academy of Neurology https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Kulkarni, Rahul
Gupta, Dulari
Pujari, Shripad
Deshpande, Vishal
Naphade, Pravin
Deshpande, Rushikesh
Neurological Manifestations in COVID-19 in Three Waves of the Pandemic: An Inpatient Study from India
title Neurological Manifestations in COVID-19 in Three Waves of the Pandemic: An Inpatient Study from India
title_full Neurological Manifestations in COVID-19 in Three Waves of the Pandemic: An Inpatient Study from India
title_fullStr Neurological Manifestations in COVID-19 in Three Waves of the Pandemic: An Inpatient Study from India
title_full_unstemmed Neurological Manifestations in COVID-19 in Three Waves of the Pandemic: An Inpatient Study from India
title_short Neurological Manifestations in COVID-19 in Three Waves of the Pandemic: An Inpatient Study from India
title_sort neurological manifestations in covid-19 in three waves of the pandemic: an inpatient study from india
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9996479/
https://www.ncbi.nlm.nih.gov/pubmed/36911448
http://dx.doi.org/10.4103/aian.aian_204_22
work_keys_str_mv AT kulkarnirahul neurologicalmanifestationsincovid19inthreewavesofthepandemicaninpatientstudyfromindia
AT guptadulari neurologicalmanifestationsincovid19inthreewavesofthepandemicaninpatientstudyfromindia
AT pujarishripad neurologicalmanifestationsincovid19inthreewavesofthepandemicaninpatientstudyfromindia
AT deshpandevishal neurologicalmanifestationsincovid19inthreewavesofthepandemicaninpatientstudyfromindia
AT naphadepravin neurologicalmanifestationsincovid19inthreewavesofthepandemicaninpatientstudyfromindia
AT deshpanderushikesh neurologicalmanifestationsincovid19inthreewavesofthepandemicaninpatientstudyfromindia